Sirio Pharma Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 702.16 million compared to CNY 421.25 million a year ago. Revenue was CNY 702.16 million compared to CNY 421.25 million a year ago.

Net income was CNY 29.4 million compared to CNY 14.64 million a year ago. Basic earnings per share from continuing operations was CNY 0.1629 compared to CNY 0.0812 a year ago.